JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online February 17, 2009, 10.2967/jnmt.108.058172
doi:10.2967/jnmt.108.058172
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnmt.108.058172v1
37/1/53    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Carvalho, A. B.
Right arrow Articles by Garcia, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Carvalho, A. B., Jr.
Right arrow Articles by Garcia, F.
Journal of Nuclear Medicine Technology Volume 37, Number 1, 2009 53-56
© 2009 by Society of Nuclear Medicine

Use of a Voxel Phantom as a Source and a Second Voxel Phantom as a Target to Calculate Effective Doses in Individuals Exposed to Patients Treated with 131I

Albérico B. de Carvalho, Jr.1, John Hunt2, Ademir X. Silva3 and Fermin Garcia1

1 Departamento de Ciências Exatas e Tecnológicas, Universidade Estadual de Santa Cruz, Ilhéus, Brazil; 2 Instituto de Radioproteção e Dosimetria, Rio de Janeiro, Brazil; and 3 Programa de Engenharia Nuclear/COPPE/Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Correspondence: For correspondence or reprints contact: Albérico B. de Carvalho, Jr., Departamento de Ciências Exatas e Tecnológicas, Universidade Estadual de Santa Cruz, Rodovia Ilhéus-Itabuna, Km 16, Ilhéus, Bahia 45650-000, Brazil. E-mail: ablohem{at}gmail.com

In this study, the Visual Monte Carlo radiation transport code and the female voxel phantom FAX were used to calculate organ and effective doses delivered by target–source irradiation geometries associated with radioiodine therapy treatments. Methods: Specific situations were considered: when a patient was accompanied during hospitalization, when a patient was accompanied on return to his or her residence, and when a patient received daily care at home. Results: This simulation study showed that, in the 3 situations considered, the total effective dose to an individual in normal contact with the patient was less than 0.85 mSv for up to 11.1 GBq (300 mCi) of administered activity. Conclusion: The results of this study suggest that for these patients receiving radioiodine therapy, radiation protection procedures after hospital discharge are unnecessary.

Key Words: radionuclide therapy; patient release; radiation safety; dosimetry; Monte Carlo method







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2009 by the Society of Nuclear Medicine Technologist Section.